SWEDISH ORPHAN BIO U/ADR by Swedish Orphan Biovitrum AB (SWOBY)

About SWEDISH ORPHAN BIO U/ADR by Swedish Orphan Biovitrum AB (SWOBY)

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The Immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Stockholm, Sweden.

SWEDISH ORPHAN BIO U/ADR by Swedish Orphan Biovitrum AB News